IMPLANT SITE NERVE INJURY

IMPLANT SITE NERVE INJURY was reported 32 times

IMPLANT SITE NERVE INJURY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Progestin [EPC] 21 0.0001
1 Integrin Receptor Antagonist [EPC] 2 0.0000
2 Glycopeptide Antibacterial [EPC] 1 0.0000
3 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
4 Estrogen [EPC] 1 0.0000
5 GLP-1 Receptor Agonist [EPC] 1 0.0000